A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

NCT01393743 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

163

Enrollment

INDUSTRY

Sponsor class

Conditions

Seizure Disorder Generalized Tonic Clonic

Interventions

DRUG: Perampanel
DRUG: Placebo comparator

Sponsor

Eisai Inc.